Press Releases

Below you will find a list of LEO Pharma's most recent global and affiliate-issued press releases, relevant to LEO Pharma Inc., LEO Pharma’s U.S. business. These press releases are intended for use by media. Please note that you will be linking out to the LEO Pharma global website or the news wire to access these press releases.  

4-28-20 LEO Pharma Inc. Donates $25,000 to New Jersey Pandemic Relief Fund   

4-15-20 LEO Pharma Inc. Announces Availability of Finacea® (azelaic acid) Foam, 15%, for Treatment of Mild-to-Moderate Rosacea

3-15-20 Update from LEO Pharma Inc. on COVID-19​

12-11-19 LEO Pharma announces positive top-line results for tralokinumab from three Phase 3 studies in adult patients with moderate-to-severe AD

8-27-19 LEO Pharma Files IND Application to FDA for a Clinical Study of JW1601/LP0190 in the US

8-1-19 LEO Pharma Inc. Announces U.S. Food and Drug Administration (FDA) Expanded Regulatory Approvals for Enstilar® Foam and Taclonex® Topical Suspension in Treatment of Plaque Psoriasis

6-3-2019 LEO Pharma appoints Catherine Mazzacco as new CEO

5-10-2019 LEO Pharma Strengthens US footprint and Global Development Team with appointment of Vice Presidents for Global Regulatory Affairs and Global Project Management

4-9-2019 LEO Pharma and Elektrofi expand partnership to co-develop new antibodies with the aim of achieving improvements in drug delivery within dermatology

Visit the LEO Pharma global news page for additional press releases of interest.